1/24/2012

Forty-two percent of adults who use the Internet think drugmakers should be involved in patient communities, compared with 19% who oppose pharmaceutical industry participation, a Manhattan Research survey found. "This emphasizes why it's so important that the FDA builds on the guidance they recently issued for off-label discussions," said Maureen Malloy, senior health care analyst with the firm. "Patients are calling, and many brands are trying to determine how to respond."

Full Story:
PMLive.com (U.K.)

Related Summaries